Henry Chen
Chief Executive Officer at Curamir Therapeutics, Inc.
Profile
Henry Chen is the founder and currently serves as the Managing Partner at Delos Advisors Ltd., a company he founded in 2014.
He is also the founder and Chief Executive Officer of Curamir Therapeutics, Inc., which is established in 2019.
In addition to his founding positions, Mr. Chen previously held the role of Chief Executive Officer at Tanvex BioPharma USA, Inc. from 2020 to 2021.
Prior to that, he was a Partner & Co-Head at Permira Advisers (China) Ltd.
from 2008 to 2014.
Mr. Chen obtained his undergraduate degree from Harvard Law School in 1996.
Henry Chen active positions
Companies | Position | Start |
---|---|---|
Curamir Therapeutics, Inc.
Curamir Therapeutics, Inc. BiotechnologyHealth Technology Curamir Therapeutics, Inc. engages in the provision of biotechnology company specializing in micro RNA (miRNA) based cancer therapeutics. The company was founded by Henry Chen, Jingfang Ju, James D. Watson, and Lan Bo Chen and is headquartered in Woburn, MA. | Chief Executive Officer | 2018-12-31 |
Delos Advisors Ltd.
Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Founder | 2014-11-30 |
Former positions of Henry Chen
Companies | Position | End |
---|---|---|
Tanvex BioPharma USA, Inc. | Chief Executive Officer | 2021-09-30 |
Permira Advisers (China) Ltd. | Public Communications Contact | 2014-11-30 |
Training of Henry Chen
Harvard Law School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Tanvex BioPharma USA, Inc. | |
Permira Advisers (China) Ltd. | Finance |
Delos Advisors Ltd.
Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Finance |
Curamir Therapeutics, Inc.
Curamir Therapeutics, Inc. BiotechnologyHealth Technology Curamir Therapeutics, Inc. engages in the provision of biotechnology company specializing in micro RNA (miRNA) based cancer therapeutics. The company was founded by Henry Chen, Jingfang Ju, James D. Watson, and Lan Bo Chen and is headquartered in Woburn, MA. | Health Technology |
- Stock Market
- Insiders
- Henry Chen